The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Clinical trial NCT00097344 · TERMINATED

Trial details

NCT number: NCT00097344
Sponsor: Intarcia Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Neoplasms, Hormone-Dependent

Start date: 2004-12-01
Enrollment: 842

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.